iSpecimen Inc. financial data

Symbol
ISPC on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
450 Bedford Street, Suite 1010, Lexington, MA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 132 % -74.2%
Debt-to-equity 59.9 % +174%
Return On Equity -115 % -95%
Return On Assets -72.1 % -48.6%
Operating Margin -97.5 % +13%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.1M shares +44.5%
Common Stock, Shares, Outstanding 13.1M shares +44.5%
Entity Public Float 10.4M USD -20.5%
Common Stock, Value, Issued 1.31K USD +44.5%
Weighted Average Number of Shares Outstanding, Basic 11.3M shares +25.5%
Weighted Average Number of Shares Outstanding, Diluted 9.13M shares +1.69%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.5M USD +3.82%
Selling and Marketing Expense 3.76M USD +2.11%
General and Administrative Expense 5.52M USD -22.5%
Costs and Expenses 20.8M USD -3.32%
Operating Income (Loss) -10.2M USD +9.69%
Nonoperating Income (Expense) 52.1K USD -70.4%
Net Income (Loss) Attributable to Parent -10.2M USD +8.73%
Earnings Per Share, Basic -1.08 USD/shares +13.6%
Earnings Per Share, Diluted -1.28 USD/shares -10.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.15M USD +7.32%
Marketable Securities, Current 6.21M USD
Cash, Cash Equivalents, and Short-term Investments 2.15M USD
Accounts Receivable, after Allowance for Credit Loss, Current 893K USD -38.8%
Assets, Current 5.24M USD -52.3%
Property, Plant and Equipment, Net 105K USD -36%
Operating Lease, Right-of-Use Asset 26.5K USD -75.2%
Other Assets, Noncurrent 213K USD
Assets 11.9M USD -32.3%
Accounts Payable, Current 4.21M USD +136%
Accrued Liabilities, Current 1.32M USD +49.5%
Liabilities, Current 5.81M USD +103%
Operating Lease, Liability, Noncurrent 29.1K USD +6.33%
Liabilities 5.81M USD +103%
Accumulated Other Comprehensive Income (Loss), Net of Tax 41 USD -99.8%
Retained Earnings (Accumulated Deficit) -64.4M USD -18.8%
Stockholders' Equity Attributable to Parent 6.09M USD -58.6%
Liabilities and Equity 11.9M USD -32.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.07M USD +26.7%
Net Cash Provided by (Used in) Financing Activities -119K USD -275%
Net Cash Provided by (Used in) Investing Activities 1.94M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 13.1M shares +44.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.15M USD +7.32%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.47K USD +26.3%
Deferred Tax Assets, Valuation Allowance 15.2M USD +33.1%
Deferred Tax Assets, Gross 15.4M USD +30.8%
Operating Lease, Liability 29.1K USD -73%
Depreciation 73.9K USD -17%
Payments to Acquire Property, Plant, and Equipment 9.14K USD +13.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.11M USD +39.8%
Lessee, Operating Lease, Liability, to be Paid 29.3K USD -73.4%
Property, Plant and Equipment, Gross 582K USD +2.62%
Operating Lease, Liability, Current 29.1K USD -73%
Lessee, Operating Lease, Liability, to be Paid, Year Two 29.3K USD +6.33%
Lessee, Operating Lease, Liability, to be Paid, Year One 41.4K USD -74.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 218 USD -91%
Lessee, Operating Lease, Liability, to be Paid, Year Three 29.3K USD
Deferred Tax Assets, Operating Loss Carryforwards 12.6M USD +24.3%
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 70.5M USD +2.29%
Amortization of Intangible Assets 47.9K USD
Share-based Payment Arrangement, Expense 18.1K USD -40.8%
Interest Expense 17.9K USD -89.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%